Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2008.
Current awareness: Pharmacoepidemiology and drug safety.
Pharmacoepidemiology and Drug Safety,
Vol. 17,
Issue. 6,
Hong, Bin Na
Yi, Tae Hoo
Kim, Sun Yeou
and
Kang, Tong Ho
2008.
High Dosage Sildenafil Induces Hearing Impairment in Mice.
Biological and Pharmaceutical Bulletin,
Vol. 31,
Issue. 10,
p.
1981.
Baldwin, Kathleen A.
Budzinski, Cynthia E.
and
Shapiro, Craig J.
2008.
Acute Sensorineural Hearing Loss: Furosemide Ototoxicity Revisited.
Hospital Pharmacy,
Vol. 43,
Issue. 12,
p.
982.
Chen, Huang-Chi
Wang, Chuan-Sheng
Chuang, Shu-Hui
and
Wang, Cheng-Yuan
2008.
Pulmonary embolism after tadalafil ingestion.
Pharmacy World & Science,
Vol. 30,
Issue. 5,
p.
610.
Azuri, J
Gelerenter, R
Dushinat, M
Friedman, N
and
Kokia, E
2009.
Raising awareness for the diagnosis and treatment of erectile dysfunction in patients with high risk to develop ED.
International Journal of Impotence Research,
Vol. 21,
Issue. 4,
p.
249.
Verhaeghe, R.
and
Verhamme, P.
2009.
Vol. 31,
Issue. ,
p.
345.
Maddox, Patrick T.
Saunders, James
and
Chandrasekhar, Sujana S.
2009.
Sudden hearing loss from PDE‐5 inhibitors: A possible cellular stress etiology.
The Laryngoscope,
Vol. 119,
Issue. 8,
p.
1586.
Giuliano, F.
Jackson, G.
Montorsi, F.
Martin-Morales, A.
and
Raillard, P.
2009.
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.
International Journal of Clinical Practice,
Vol. 64,
Issue. 2,
p.
240.
Shindel, Alan W.
2009.
Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME).
The Journal of Sexual Medicine,
Vol. 6,
Issue. 9,
p.
2352.
Okuyucu, S
Guven, O E
Akoglu, E
Uçar, E
and
Dagli, S
2009.
Effect of phosphodiesterase-5 inhibitor on hearing.
The Journal of Laryngology & Otology,
Vol. 123,
Issue. 7,
p.
718.
Mazurek, Birgit
Haupt, Heidemarie
Szczepek, Agnieszka J
Sandmann, Jörg
Gross, Johann
Klapp, Burghard F
Kiesewetter, Holger
Kalus, Ulrich
Stöver, Timo
and
Caffier, Philipp P
2009.
Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study.
Journal of Negative Results in BioMedicine,
Vol. 8,
Issue. 1,
Taylor, Robert B.
2010.
Medical Wisdom and Doctoring.
p.
177.
Taylor, Robert B.
2010.
Medical Wisdom and Doctoring.
p.
107.
Khan, Afroze Shah
Sheikh, Zishan
Khan, Shahnawaz
Dwivedi, Raghav
and
Benjamin, Elliot
2011.
Viagra deafness—Sensorineural hearing loss and phosphodiesterase‐5 inhibitors .
The Laryngoscope,
Vol. 121,
Issue. 5,
p.
1049.
Son, Su Bin
Kim, Kyung Ah
Yun, So Young
Ko, Sun Young
Lee, Yeon Kyung
and
Shin, Son Moon
2011.
Oral Sildenafil in Persistent Pulmonary Hypertension of the Newborn.
Journal of the Korean Society of Neonatology,
Vol. 18,
Issue. 1,
p.
124.
Al-Shaiji, Tariq F.
Chung, Eric
and
Brock, Gerald B.
2011.
Cancer and Sexual Health.
p.
675.
Bakir, Salih
Firat, Uğur
Gün, Ramazan
Bozkurt, Yaşar
Yorgancilar, Ediz
Kiniş, Vefa
Penbegül, Necmettin
Gökalp, Osman
and
Topçu, İsmail
2012.
Histopathologic results of long-term sildenafil administration on rat inner ear.
American Journal of Otolaryngology,
Vol. 33,
Issue. 6,
p.
667.
Selvakumar, Dakshnamurthy
Drescher, Marian J.
Dowdall, Jayme R.
Khan, Khalid M.
Hatfield, James S.
Ramakrishnan, Neeliyath A.
and
Drescher, Dennis G.
2012.
CNGA3 is expressed in inner ear hair cells and binds to an intracellular C-terminus domain of EMILIN1.
Biochemical Journal,
Vol. 443,
Issue. 2,
p.
463.
Kim, Kun Woo
Lee, Jae Wook
Jung, Jae Yun
and
Suh, Myung-Whan
2012.
Acute Unilateral Vestibular Weakness Following Sildenafil Ingestion.
Korean Journal of Otorhinolaryngology-Head and Neck Surgery,
Vol. 55,
Issue. 8,
p.
513.
Barreto, Monique Antunes de Souza Chelminski
and
Bahmad, Fayez
2013.
Phosphodiesterase Type 5 Inhibitors and sudden sensorineural hearing loss.
Brazilian Journal of Otorhinolaryngology,
Vol. 79,
Issue. 6,
p.
727.